NONSQUAMOUS NON-SMALL CELL LUNG CANCER
Clinical trials for NONSQUAMOUS NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSQUAMOUS NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSQUAMOUS NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail therapy shows promise for lung cancer patients
Disease control CompletedThis study tested whether adding lenvatinib to standard chemotherapy plus pembrolizumab helps adults with advanced nonsquamous non-small cell lung cancer live longer or delay cancer growth. Participants were from mainland China and had not received prior treatment for metastatic …
Matched conditions: NONSQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
New cocktail therapy shows promise for tough lung cancer
Disease control CompletedThis study tested whether adding a fourth drug (lenvatinib) to a standard three-drug regimen (chemotherapy plus immunotherapy) helps people with advanced non-small cell lung cancer live longer or keep their cancer from growing. About 761 adults with a specific type of lung cancer…
Matched conditions: NONSQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 08:29 UTC